Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1991 1
1993 1
1997 1
1998 1
1999 2
2000 3
2001 1
2005 1
2006 2
2007 1
2012 1
2015 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Angiozyme: a novel angiogenesis inhibitor.
Weng DE, Usman N. Weng DE, et al. Curr Oncol Rep. 2001 Mar;3(2):141-6. doi: 10.1007/s11912-001-0014-7. Curr Oncol Rep. 2001. PMID: 11177746 Review.
Differential gene expression in fetal mouse germ cells.
Urven LE, Weng DE, Schumaker AL, Gearhart JD, McCarrey JR. Urven LE, et al. Among authors: weng de. Biol Reprod. 1993 Mar;48(3):564-74. doi: 10.1095/biolreprod48.3.564. Biol Reprod. 1993. PMID: 8452933
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors.
Weng DE, Masci PA, Radka SF, Jackson TE, Weiss PA, Ganapathi R, Elson PJ, Capra WB, Parker VP, Lockridge JA, Cowens JW, Usman N, Borden EC. Weng DE, et al. Mol Cancer Ther. 2005 Jun;4(6):948-55. doi: 10.1158/1535-7163.MCT-04-0210. Mol Cancer Ther. 2005. PMID: 15956252 Free article. Clinical Trial.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page